These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26900078)

  • 1. An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.
    Murphy A; Dursun S; McKie S; Elliott R; Deakin JF
    Psychopharmacology (Berl); 2016 Apr; 233(8):1415-26. PubMed ID: 26900078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study.
    Goozee R; Reinders AATS; Handley R; Marques T; Taylor H; O'Daly O; McQueen G; Hubbard K; Mondelli V; Pariante C; Dazzan P
    Schizophr Res; 2016 Jun; 173(3):174-181. PubMed ID: 25778615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-HT
    Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
    Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [
    Shin S; Kim S; Seo S; Lee JS; Howes OD; Kim E; Kwon JS
    Transl Psychiatry; 2018 Apr; 8(1):87. PubMed ID: 29686254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
    Tadori Y; Miwa T; Tottori K; Burris KD; Stark A; Mori T; Kikuchi T
    Eur J Pharmacol; 2005 May; 515(1-3):10-9. PubMed ID: 15894311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
    Tadori Y; Kikuchi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):9-18. PubMed ID: 22568121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical impact of aripiprazole in patients suffering from schizophrenia].
    Levoyer D; Drapier D; Fadier-Salicé G; Millet B
    Encephale; 2007; 33(3 Pt 1):332-8. PubMed ID: 17675931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2008 Nov; 597(1-3):27-33. PubMed ID: 18831971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.
    Kim E; Howes OD; Turkheimer FE; Kim BH; Jeong JM; Kim JW; Lee JS; Jang IJ; Shin SG; Kapur S; Kwon JS
    Psychopharmacology (Berl); 2013 May; 227(2):221-9. PubMed ID: 23271192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
    Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
    Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.
    Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
    Neuropharmacology; 2012 Feb; 62(2):765-74. PubMed ID: 21925189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.
    Aihara K; Shimada J; Miwa T; Tottori K; Burris KD; Yocca FD; Horie M; Kikuchi T
    Brain Res; 2004 Apr; 1003(1-2):9-17. PubMed ID: 15019558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.
    De Santis M; Lian J; Huang XF; Deng C
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2011 Oct; 668(3):355-65. PubMed ID: 21816144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2009 Apr; 607(1-3):35-40. PubMed ID: 19217900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.